Pharmaceutical Technology Europe-05-03-2011

Pharmaceutical Technology Europe

May 03, 2011

As I strolled through Times Square, famous brand coffee cup in hand, towards the Jacob K. Javits Convention Center in New York, my thoughts were entirely focused on Interphex.

Special Feature
Pharmaceutical Technology Europe

May 02, 2011

Extending a drug product's shelf life while maintaining its strength, quality and purity is a challenge for pharma companies.

Special Feature
Pharmaceutical Technology Europe

May 02, 2011

There are a number of points to consider where secondary packaging is concerned.

Special Feature
Pharmaceutical Technology Europe

May 02, 2011

Legislation has prompted the pharma industry to seek technologies that can be used to secure a product throughout the supply chain.

Special Feature
Pharmaceutical Technology Europe

May 02, 2011

More challenges face the pharma packaging industry today than ever before, according to Domino Printing Sciences' global life sciences sector manager.

Pharmaceutical Technology Europe

In light of the challenges facing the pharma industry, such as changing patient demands and changing demographics, the relationship between the packaging, the consumer and the product is being completely reconsidered.

News
Pharmaceutical Technology Europe

May 02, 2011

Outsourcing can have its benefits, but how often do we bother to measure the actual value of our outsourcing relationships?

Pharmaceutical Technology Europe
Special Feature

May 02, 2011

Research conducted in the UK by the University of Leeds and Luto Research shows that many commonly-used phrases on medicine labels are easily misunderstood.

Industry Insider
Pharmaceutical Technology Europe

May 01, 2011

Despite initiatives to encourage multinational pharma companies to conduct R&D in the UK, the country may be losing its edge; is Pfizer's decision to exit a key site earlier this year the beginning of a mass exodus?

Pharmaceutical Technology Europe

A large CMO explains its strategies for expanding into the emerging markets.